Dabrafenib + Trametinib for cancer treatmentz
Dear Orkney NHS Board,
Please answer these questions relating to the usage of Dabrafenib + Trametinib in cancer treatment.
A) Over the previous 6 months, how many patients for the following diseases have been treated with a combination of Dabrafenib + Trametinib:
i) Metastatic Melanoma
ii) Adjuvant Melanoma
iii) BRAF mutated Lung Cancer
I sincerely thank you for taking the time to answer these questions.
Yours faithfully,
David Elder
FOI Request – Acknowledgement of Receipt
I hereby acknowledge receipt of the request below:
Reference number allocated to this request:
202223-118
(Please quote this reference number in any future correspondence relating to this request.)
The official date of your request is:
29/06/2022
A response should be sent to your request no later than:
27/07/2022
Note: NHS Orkney is a small remote and rural health board within Scotland. All responses to Freedom of Information requests are collated in accordance with the terms of the Freedom of Information (Scotland) Act 2002.
The Freedom of Information (Scotland) Act 2002 states that a public authority must inform the applicant in writing whether it holds the requested information and if so, communicate that information to the applicant, promptly, but not later than 20 working days after receipt of the request.
For further details please refer to The Scottish Information Commissioner’s website.
Sent by:
Freedom of Information Office
NHS Orkney
The Balfour,
Foreland Road,
Kirkwall,
KW15 1NZ
Dear Mr. Elder,
Please find attached the response to your FOI request form NHS Orkney.
Kind regards,
Jenna
Jenna Johnston
Freedom of Information (FOI) Officer
The Balfour, Foreland Road, Kirkwall, KW15 1NZ
Tel: 01856 888220
FOI Requests e-mail: [email address]
Subject Access Requests e-mail: [email address]
Please note days of work: Monday and Thursday
We work to defend the right to FOI for everyone
Help us protect your right to hold public authorities to account. Donate and support our work.
Donate Now